BUNKER KEVIN D. (Chief Operating Officer) received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/3/2022ACC: 0001725160-22-000179
Officer· Chief Operating Officer
Since Apr 2020
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
6.5%
10/3/2022
764.11K→814.11K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/3/2022 | A · Award | +50K | — | — | 6.5% | 764.11K | 814.11K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
22.21
Held after
50K
Exercisable
—
10/3/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 10/3/2022 | A · Award | +50K | 22.21 | — | 50K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned350.00
Common Stock
IndirectShares owned95K
Total
95.35K indirect95.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 350.00 | Indirect |
| Common Stock | 95K | Indirect |
| Total | 95.35K | 95.35K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported